Manual práctico de Trombosis y Hemostasia de la SETH

— 2 4 1 — 7. O b s t e t r i c i a , a n t i c o n c e p c i ó n y t r a t a m i e n t o h o r m o n a l s u s t i t u t i v o 9 th ed. American College of Chest Physicians Evidence- Based Clinical Practice Guidelines. Chest 2012;141(Suppl 2): e691S-e736S. 10. Brill-Edwards P, Ginsberg JS, Gent M, Hirsh J, Burrows R, Kearon C, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this pregnancy study group. N Engl J Med 2000;343:1439-444. 11. Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol 2010;56:1-7. 12. Royal College of Obstetricians and Gynaecologists Green-top guideline No. 37a. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium 2015. 13. Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thrombo-embolism . J Thromb Thrombolysis 2016:41:92-128. 14. Guimicheva B, Czuprynska J, Aya R. The prevention of preg- nancy-related venous thromboembolism. Br J Haematol 2015; 168:163-74. 15. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M et al. Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated he- parin. N Engl J Med 1994;332:1330-5. 16. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembo- lism in pregnancy: a systematic review of safety and efficacy. Blood 2005;106:401-7. 17. Greer IA. Pregnancy complicated by venous thrombosis. N Engl J Med 2015;373:540-7. 18. Chan WS, Ray JG, Murray S, Coady GE, Coates G, Ginsberg JS. Suspected pulmonary embolism in pregnancy: clinical presenta- tion, results of lung scanning, and subsequent maternal and pedia- tric outcomes. Arch Intern Med 2002;162:1170-5. 19. Royal College of Obstetricians and Gynaecologists Green-top guideline No. 37b. Thromboembolic disease in pregnancy and the puerperium: acute management. 2015. Available from: ht- tps://ww.rcog.org.uk/en/guidelines-research-services/guideli- nes/gtg37b/ 20. Chan WS, Spencer FA, Lee AY, Chunilal S, Douketis JD, Marc Rodger, et al. Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following nega- tive serial compression ultrasound and iliac vein imaging. CMAJ 2013;185: E194-E200. 21. Simcox LE, Ormesher L, Tower C, Greer IA. Pulmonary throm- bo-embolism in pregnancy: diagnosis and management. Breathe 2015:11:282-9. 22. Ridge CA, McDermott S, Freyne BJ, Brennan DJ, Collins CD, Skehan SJ, et al. Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy. AJR Am J Roentgenol 2009;193:1223-7. 23. Khan F, Vaillancourt C, Bourjeily G. Diagnosis and management of deep vein thrombosis in pregnancy. BMJ 2017;357:j2344. DOI: 10.1136/bmj.j2344 24. Voke J, Keidan J, Pavord S, Spencer HN, Hunt BJ, on behalf of the British Society of Haematology Obstetric Haematology Group. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational study. Br J Haematol 2007;139:545-8. 25. McDonell BP, Glennon K, McTiernan A, O’Connor HD, Kirkham C, Kevane B, et al. Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in preg- nant patients with venous thromboembolism. J Thromb Throm- bolysis 2017;43:105-11. 26. Te Raa GD, Ribbert LSM, Snijder RJ, Biesma DH. Treatment options in massive pulmonary embolism during pregnancy; a case- report and review of literature.Thromb Res 2009;124:1-5. 27. Harris SA,Velineni R, Davies AH. Inferior vena cava filters in preg- nancy: a systematic review. J Vasc Interv Radiol 2016;27:354-60. 28. Rattray DD, O´Connell CM, Baskett TF. Acute disseminated intra-vascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can 2012;34:341-7. 29. Cunningham FG, Nelson DB Disseminated Intravascular Coa- gulation Syndromes in Obstetrics. Obstet Gynecol 2015;126: 999-1001 30. Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coa- gulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol 2015;213:452-63. 31. Erez O. Disseminated intravascular coagulation in pregnancy. Clinical phenotypes and diagnostic scores Thromb Res 2017;15 (Suppl.1):S56-S60 32. Levi M. Guidelines for the diagnosis and management of dissemi- nated intravascular coagulation. British Comitte for Standards in Haematology. Br J Haematol 2009;145:24-33. 33. American College of Obstetricians and Gynecologists. Practi- ce Bulletin no. 183: Postpartum Hemorrhage. Obstet Gynecol 2017;130:e168-e186. 34. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Kei- ta H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5:266-73. 35. Maegele M, Schochl H, Cohen MJ. An update on the coagulopa- thy of trauma. Shock 2014;41(Suppl 1):21-5. 36. Stafford I, Dildy G, Clark S, Belfort M.Visually estimated and cal- culated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol 2008;199:519.e1-7. 37. Llau JV, Acosta FJ, Escolar G, Fernández-Mondéjard E, Guasche E, Marco P, et al Documento multidisciplinar de consenso sobre el manejo de la hemorragia masiva (documento HEMOMAS). Medicina Intensiva 2015; 39: 483-504. 38. Wikkelso A,Wetterslev J, Moller AM.Thromboelastograph (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treat- ment versus usual care in adults or children with bleeding. Co- chrane Database Syst Rev 2015:8CD007871. 39. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidi- ties in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017;389: 2105-16. 40. Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost 2003;1:1371-80. 41. Hoffman M, Monroe DM 3 rd . A cell-based model of hemostasis. Thromb Haemost 2001;85: 958-65. 42. Kujovich JL.Von Willebrand’s disease and menorrhagia: prevalen- ce, diagnosis, and management. Am J Hematol 2005;79:220-8.